Acuity RM Group plc (ACRM), the software group specialising in cyber-security, which supplies its award-winning STREAM software platform for the Governance, Risk and Compliance (“GRC”) market, together with associated consultancy services,
Acuity RM Group plc (ACRM), the software group specialising in cyber-security, which supplies its award-winning STREAM software platform for the Governance, Risk and Compliance (“GRC”) market, together with associated consultancy services,
The FTSE 100 edged higher on Friday, closing up 23 points, or 0.3%, at 8,554.80 after a hesitant start, as easing trade war tensions lifted investor sentiment. The mid-cap FTSE
Conroy Gold and Natural Resources (CGNR) announced it has discovered antimony-bearing float samples from its Clontibret gold deposit area in County Monaghan, Ireland. The samples returned very high gold grades of
Response to Press Speculation Possible Acquisition of MiniMBA
ImmuPharma (IMM), the specialist drug discovery and development company, announced its interim results for the six months ended 30 June 2024. On 3 June 2024. ImmuPharma divested its investment in shares
Ondo Insurtech (ONDO), a claims prevention technology company for home insurers, announced further expansion of its operations in the United States. ONDO said the Customer Success role is a key hire
Tirupati Graphite (TGR), the specialist Flake Graphite company, announced its response to the notice of requisition on behalf of a group of underlying shareholders representing c. 5.8% of the issued ordinary
Possible all-share takeover to create one of the largest independent / UK-focused digital media, marketing and technology services companies listed on AIM
It is all too easy in life to do an Ian Hislop and make a living out of taking potshots at the failings or alleged failings of others. This is
Regarding the broader junior market, the AIM All-Share Index experienced a significant boost, climbing 1.75% in a week which was generally positive for the stock market.
Ananda Developments (AQSE: ANA), a company whose ambition is to be a leading provider of cannabinoid-based medicines said it was pleased to announce the appointment of Professor Cherry Wainwright and Dr.
Poolbeg Pharma (POLB), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announced its unaudited interim results for the six months to 30 June 2023.